Raymond Steitz - Aadi Bioscience Senior Officer
| AADIDelisted Stock | USD 2.05 0.05 2.38% |
Executive
Raymond Steitz is Senior Officer of Aadi Bioscience
| Age | 66 |
| Phone | 424 744 8055 |
| Web | https://aadibio.com |
Aadi Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Francis Burrows | Kura Oncology | N/A | |
| Andrew Funderburk | Monte Rosa Therapeutics | N/A | |
| Yan MBA | Adagene | 50 | |
| Stephen Yu | Aerovate Therapeutics | N/A | |
| Jose CPA | Mineralys Therapeutics, Common | 35 | |
| Marinus Verwijs | Aerovate Therapeutics | 48 | |
| John Grosso | Arvinas | 67 | |
| Alan MD | Crinetics Pharmaceuticals | 62 | |
| Vince Hernandez | AN2 Therapeutics | N/A | |
| Priya Raina | AnaptysBio | N/A | |
| Benjamin Stone | AnaptysBio | N/A | |
| Paul JD | Ultragenyx | N/A | |
| Ian Taylor | Arvinas | 63 | |
| Susan Fischer | Aerovate Therapeutics | N/A | |
| Mustapha Parekh | Design Therapeutics | N/A | |
| Garlan Adams | Crinetics Pharmaceuticals | N/A | |
| Samuel Wadsworth | Ultragenyx | 76 | |
| Tobin Schilke | Crinetics Pharmaceuticals | 50 | |
| Lisa Sinclair | Arvinas | N/A | |
| Mollie MD | Kura Oncology | N/A | |
| Vimal Srivastava | Ultragenyx | 60 | |
Management Performance
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 |
Aadi Bioscience Leadership Team
Elected by the shareholders, the Aadi Bioscience's board of directors comprises two types of representatives: Aadi Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aadi. The board's role is to monitor Aadi Bioscience's management team and ensure that shareholders' interests are well served. Aadi Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aadi Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Desai, President, Founder | ||
| Raymond Steitz, Senior Officer | ||
| Bryan Ball, Chief Operations | ||
| David Lennon, CEO President | ||
| Marcy Graham, SVP Communications | ||
| Stephen JD, Senior Counsel | ||
| Brendan MBA, Chief Officer | ||
| David Dornan, Chief Officer | ||
| MD FACP, Chief Officer | ||
| Scott CPA, Treasurer, CFO |
Aadi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aadi Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | 35.53 M | ||||
| Shares Outstanding | 46.29 M | ||||
| Shares Owned By Insiders | 6.09 % | ||||
| Shares Owned By Institutions | 50.02 % | ||||
| Number Of Shares Shorted | 764.36 K | ||||
| Price To Book | 1.41 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Aadi Stock
If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |